Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 04:00PM ET
Dollar change
Percentage change
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y16.94% Shs Outstand Perf Week15.23%
SponsorVirtus ETF Solutions ETF Type Tagsequity Return% 3Y-16.68% Total Holdings123 Perf Month5.22%
Fund Family Bond Type Tagsbiotechnology Return% 5Y-0.05% AUM11.45M Perf Quarter7.86%
IndexLifeSci Biotechnology Clinical Trials In... Average Maturity Tagsclinical-trials Return% 10Y NAV% Perf Half Y16.67%
Index Weighting Commodity Type Tagsinnovation Return% SI NAV/sh Perf Year18.49%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range16.88 - 31.99 Perf YTD19.65%
Dividend TTM0.08 (0.28%) ESG Type Tags- Flows% 3M0.00% 52W High-8.55% Beta1.06
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD-9.86% 52W Low73.32% ATR (14)0.69
Expense0.79% Structure Type Region Flows% 1Y RSI (14)69.46 Volatility1.90% 1.47%
Option/ShortYes / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.92 Prev Close28.57
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.16K Price29.26
SMA2013.28% SMA509.79% SMA20019.20% Trades Volume2,912 Change2.39%
Aug-30-21 04:00PM
Aug-20-20 05:25PM
May-27-20 09:40AM
May-11-20 01:00PM
01:40PM Loading…
Feb-10-20 01:40PM
Dec-31-19 08:00AM
Dec-27-19 02:19PM
Dec-26-19 02:30PM
Dec-24-19 12:15PM
Dec-23-19 12:00PM
Dec-20-19 02:00PM
01:41PM Loading…
Dec-18-19 01:41PM
Dec-17-19 03:31PM
Dec-16-19 10:42AM
Dec-12-19 08:00AM
Dec-10-19 04:16PM
Dec-04-19 09:40AM
Dec-03-19 02:30PM
Dec-02-19 11:10AM
Nov-29-19 12:15PM
Nov-25-19 08:00AM
Nov-21-19 12:56PM
Nov-04-19 10:10AM
Oct-30-19 10:43AM
10:10AM Loading…
Oct-23-19 10:10AM
Apr-25-19 10:00AM
Mar-12-19 11:05AM
Dec-27-18 02:30PM
Dec-21-18 02:30PM
Dec-18-18 10:55AM
Nov-20-18 10:25AM
Oct-23-18 09:18AM
Sep-04-18 01:00PM
Jul-12-18 04:53PM
Jul-10-18 12:15PM
Jul-09-18 02:37PM
May-15-18 12:15PM
Apr-18-18 04:08PM
Mar-14-18 05:39PM
Feb-02-18 08:00AM
Dec-25-17 06:00AM
Dec-22-17 04:16PM
Dec-19-17 03:00PM
Sep-11-17 10:29AM
Aug-30-17 01:08PM
Aug-28-17 02:37PM
Jun-30-17 11:30AM
Jun-29-17 03:37PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 08:00AM
May-15-17 03:26PM
Apr-28-17 09:30AM
Apr-27-17 10:03AM
Apr-03-17 10:59AM
Mar-31-17 09:30AM
Mar-30-17 11:22AM
Mar-29-17 10:09AM
Mar-22-17 10:51AM
Mar-21-17 12:19PM
Mar-08-17 10:07AM
Mar-01-17 01:24PM
Feb-28-17 12:00PM
Jan-12-17 10:08AM
Jan-11-17 06:54AM
Jan-03-17 10:36AM
Dec-30-16 07:02AM
Dec-27-16 10:42PM
Dec-16-16 02:51PM
Dec-07-16 02:11PM
Nov-17-16 09:30AM
Nov-16-16 09:51AM
Oct-27-16 12:19PM
Oct-03-16 04:31PM
Sep-30-16 09:13AM
Sep-21-16 11:23AM
Sep-19-16 04:09PM
Aug-18-16 09:30AM
Aug-10-16 09:30AM
Aug-09-16 02:01PM
Jul-21-16 11:08AM
Jul-20-16 02:23PM
Jun-22-16 10:40AM
Jun-21-16 02:07PM
Jun-16-16 02:35PM
Jun-07-16 09:30AM
Jun-03-16 10:10AM
May-16-16 06:58PM
Apr-28-16 12:15PM
Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.